Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Ho Bae

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|May 26, 2009
Sensitization of human K562 leukemic cells to TRAIL-induced apoptosis by inhibiting the DNA-PKcs/Akt-mediated cell survival pathwayMi-Ju Kim, Hak-Bong Kim, Jae-Ho Bae, et al.
Experimental & Molecular Medicine|November 3, 2006
Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiationJoo-Young Kim, Young-Ok Son, Soon-Won Park, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
CTLA-4 blockade enhances antitumor immunity of intratumoral injection of immature dendritic cells into irradiated tumor in a mouse colon cancer modelCheol-Hun Son, Jae-Ho Bae, Dong-Yeok Shin, et al.
Experimental Cell Research|September 15, 2014
COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cellsSo-Jung Kim, Ga-Hee Ha, Jae-Ho Bae, et al.
Cancer Letters|January 16, 2007
Camptothecin acts synergistically with imatinib and overcomes imatinib resistance through Bcr-Abl independence in human K562 cellsDong-Sik Ju, Mi-Ju Kim, Jae-Ho Bae, et al.
Biochemical Pharmacology|April 10, 2012
Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosisHak-Bong Kim, Mi-Ju Kim, Su-Hoon Lee, et al.
The International Journal of Biochemistry & Cell Biology|December 19, 2012
Ku70 acetylation and modulation of c-Myc/ATF4/CHOP signaling axis by SIRT1 inhibition lead to sensitization of HepG2 cells to TRAIL through induction of DR5 and down-regulation of c-FLIPMi-Ju Kim, Kyung-Soo Hong, Hak-Bong Kim, et al.
Biochemical and Biophysical Research Communications|May 23, 2019
Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axisSirichat Kaowinn, Eun Jin Seo, Woong Heo, et al.
Journal of Clinical Immunology|May 29, 2007
Suppressive effect of a standardized mistletoe extract on the expression of activatory NK receptors and function of human NK cellsSoo Jung Lee, Young-Ok Son, Hyunjin Kim, et al.
Experimental & Molecular Medicine|January 5, 2006
Radiosensitization by targeting radioresistance-related genes with protein kinase A inhibitor in radioresistant cancer cellsChur Chin, Jae Ho Bae, Mi Ju Kim, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|May 26, 2009
Sensitization of human K562 leukemic cells to TRAIL-induced apoptosis by inhibiting the DNA-PKcs/Akt-mediated cell survival pathwayMi-Ju Kim, Hak-Bong Kim, Jae-Ho Bae, et al.
Experimental & Molecular Medicine|November 3, 2006
Increase of NKG2D ligands and sensitivity to NK cell-mediated cytotoxicity of tumor cells by heat shock and ionizing radiationJoo-Young Kim, Young-Ok Son, Soon-Won Park, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
CTLA-4 blockade enhances antitumor immunity of intratumoral injection of immature dendritic cells into irradiated tumor in a mouse colon cancer modelCheol-Hun Son, Jae-Ho Bae, Dong-Yeok Shin, et al.
Experimental Cell Research|September 15, 2014
COX-2- and endoplasmic reticulum stress-independent induction of ULBP-1 and enhancement of sensitivity to NK cell-mediated cytotoxicity by celecoxib in colon cancer cellsSo-Jung Kim, Ga-Hee Ha, Jae-Ho Bae, et al.
Cancer Letters|January 16, 2007
Camptothecin acts synergistically with imatinib and overcomes imatinib resistance through Bcr-Abl independence in human K562 cellsDong-Sik Ju, Mi-Ju Kim, Jae-Ho Bae, et al.
Biochemical Pharmacology|April 10, 2012
Amurensin G, a novel SIRT1 inhibitor, sensitizes TRAIL-resistant human leukemic K562 cells to TRAIL-induced apoptosisHak-Bong Kim, Mi-Ju Kim, Su-Hoon Lee, et al.
The International Journal of Biochemistry & Cell Biology|December 19, 2012
Ku70 acetylation and modulation of c-Myc/ATF4/CHOP signaling axis by SIRT1 inhibition lead to sensitization of HepG2 cells to TRAIL through induction of DR5 and down-regulation of c-FLIPMi-Ju Kim, Kyung-Soo Hong, Hak-Bong Kim, et al.
Biochemical and Biophysical Research Communications|May 23, 2019
Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axisSirichat Kaowinn, Eun Jin Seo, Woong Heo, et al.
Journal of Clinical Immunology|May 29, 2007
Suppressive effect of a standardized mistletoe extract on the expression of activatory NK receptors and function of human NK cellsSoo Jung Lee, Young-Ok Son, Hyunjin Kim, et al.
Experimental & Molecular Medicine|January 5, 2006
Radiosensitization by targeting radioresistance-related genes with protein kinase A inhibitor in radioresistant cancer cellsChur Chin, Jae Ho Bae, Mi Ju Kim, et al.
Pageof 6